CN101495838A - Reversible electrochemical sensors for polysions - Google Patents
Reversible electrochemical sensors for polysions Download PDFInfo
- Publication number
- CN101495838A CN101495838A CNA200680028701XA CN200680028701A CN101495838A CN 101495838 A CN101495838 A CN 101495838A CN A200680028701X A CNA200680028701X A CN A200680028701XA CN 200680028701 A CN200680028701 A CN 200680028701A CN 101495838 A CN101495838 A CN 101495838A
- Authority
- CN
- China
- Prior art keywords
- polyion
- film
- concentration
- sample solution
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002441 reversible effect Effects 0.000 title claims abstract description 24
- 229920000831 ionic polymer Polymers 0.000 claims abstract description 204
- 239000012528 membrane Substances 0.000 claims abstract description 123
- 230000000694 effects Effects 0.000 claims abstract description 43
- 210000004369 blood Anatomy 0.000 claims abstract description 25
- 239000008280 blood Substances 0.000 claims abstract description 25
- 102000004190 Enzymes Human genes 0.000 claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 claims abstract description 21
- 239000002532 enzyme inhibitor Substances 0.000 claims abstract description 10
- 229940125532 enzyme inhibitor Drugs 0.000 claims abstract description 10
- 238000003018 immunoassay Methods 0.000 claims abstract description 5
- 108010016290 deoxyribonucleoprotamine Proteins 0.000 claims description 140
- 239000012488 sample solution Substances 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 49
- 239000003112 inhibitor Substances 0.000 claims description 23
- 239000000446 fuel Substances 0.000 claims description 21
- 238000012360 testing method Methods 0.000 claims description 20
- 230000002255 enzymatic effect Effects 0.000 claims description 14
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 8
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 8
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 8
- 239000012491 analyte Substances 0.000 claims description 7
- 229960004405 aprotinin Drugs 0.000 claims description 4
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 claims description 3
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 claims description 3
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 claims description 3
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 abstract description 48
- 229960002897 heparin Drugs 0.000 abstract description 48
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract description 47
- 239000003792 electrolyte Substances 0.000 abstract description 38
- 238000004448 titration Methods 0.000 abstract description 19
- 238000000605 extraction Methods 0.000 abstract description 17
- 238000005259 measurement Methods 0.000 abstract description 15
- 230000002269 spontaneous effect Effects 0.000 abstract description 10
- 238000005342 ion exchange Methods 0.000 abstract description 7
- 229940048914 protamine Drugs 0.000 abstract description 3
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 102000007327 Protamines Human genes 0.000 abstract 1
- 108010007568 Protamines Proteins 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 75
- 230000004044 response Effects 0.000 description 48
- 150000002500 ions Chemical class 0.000 description 46
- 239000000523 sample Substances 0.000 description 45
- 239000000463 material Substances 0.000 description 43
- 239000011780 sodium chloride Substances 0.000 description 37
- 150000001768 cations Chemical class 0.000 description 36
- 125000000129 anionic group Chemical group 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 33
- 239000000243 solution Substances 0.000 description 31
- 239000011734 sodium Substances 0.000 description 29
- 230000008859 change Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000011088 calibration curve Methods 0.000 description 14
- 238000009792 diffusion process Methods 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 239000012088 reference solution Substances 0.000 description 13
- 239000012071 phase Substances 0.000 description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 9
- 230000004907 flux Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 7
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 7
- 239000003115 supporting electrolyte Substances 0.000 description 7
- UJHSIDUUJPTLDY-UHFFFAOYSA-N (2-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 UJHSIDUUJPTLDY-UHFFFAOYSA-N 0.000 description 6
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 6
- -1 heparin compound Chemical class 0.000 description 6
- 239000004800 polyvinyl chloride Substances 0.000 description 6
- 229920000915 polyvinyl chloride Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 150000001642 boronic acid derivatives Chemical class 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 238000003918 potentiometric titration Methods 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical group CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 239000005766 Dodine Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920000447 polyanionic polymer Polymers 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 108010039627 Aprotinin Proteins 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007799 cork Substances 0.000 description 3
- 239000008151 electrolyte solution Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 3
- MSYSDQBIFATOQW-UHFFFAOYSA-N 3,9-diethyltridecan-6-yl hydrogen sulfate Chemical compound CCCCC(CC)CCC(OS(O)(=O)=O)CCC(CC)CC MSYSDQBIFATOQW-UHFFFAOYSA-N 0.000 description 2
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012490 blank solution Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 2
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 2
- VICYBMUVWHJEFT-UHFFFAOYSA-N dodecyltrimethylammonium ion Chemical compound CCCCCCCCCCCC[N+](C)(C)C VICYBMUVWHJEFT-UHFFFAOYSA-N 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 229940021013 electrolyte solution Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000004021 humic acid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920001897 terpolymer Polymers 0.000 description 2
- 238000000954 titration curve Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- CXVOIIMJZFREMM-UHFFFAOYSA-N 1-(2-nitrophenoxy)octane Chemical compound CCCCCCCCOC1=CC=CC=C1[N+]([O-])=O CXVOIIMJZFREMM-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229910013594 LiOAc Inorganic materials 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 102100023152 Scinderin Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- URSLCTBXQMKCFE-UHFFFAOYSA-N dihydrogenborate Chemical compound OB(O)[O-] URSLCTBXQMKCFE-UHFFFAOYSA-N 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- QILSFLSDHQAZET-UHFFFAOYSA-N diphenylmethanol Chemical compound C=1C=CC=CC=1C(O)C1=CC=CC=C1 QILSFLSDHQAZET-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- FCQJEPASRCXVCB-UHFFFAOYSA-N flavianic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FCQJEPASRCXVCB-UHFFFAOYSA-N 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 238000005184 irreversible process Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N n-decyl alcohol Natural products CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108010073419 scinderin Proteins 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/333—Ion-selective electrodes or membranes
- G01N27/3335—Ion-selective electrodes or membranes the membrane containing at least one organic component
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ecology (AREA)
- Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention is directed to a reversible electrochemical sensor for polyions. The sensor uses active extraction and ion stripping, which are controlled electrochemically. Spontaneous polyion extraction is suppressed by using membranes containing highly lipophilic electrolytes that possess no ion-exchange properties. Reversible extraction of polyions is induced by constant current pulse of fixed duration applied across the membrane. Subsequently, polyions are removed by applying a constant stripping potential. The sensors provide excellent stability and reversibility and allow for measurements of heparin concentration in whole blood samples via protamine titration. The sensors can also monitor a polyion concentration and an enzyme activity, wherein the polyion decomposition is directly proportional to the enzyme activity in a sample. Additionally, the sensors can monitor an enzyme inhibitor activity. Also, an immunoassay can be used to detect analytes by employing one of a polyion and an enzyme as markers.
Description
Related application
Present patent application is that the name of application on July 8th, 2004 is called the Application No. 10/887 of " reversible electrochemical sensors that is used for polyion ", 251 continuation-in-part application, it requires the U.S. Provisional Application number 60/485 of on July 9th, 2003 application, 856 right of priority, Application No. 10/887 with application on July 8th, 2004, both all are incorporated herein by reference the U.S. Provisional Application of on July 9th, 251 and 2003 application number 60/485,856 at this.
According to 35U.S.C. § 119 (e), the application also requires application time on August 5th, 2005 U.S. Provisional Patent Application (sequence number 60/706 co-pending, 117 and name be called " utilizing enzymatic activity Electrochemical Detection and the polyion selectivity reversible electrochemical sensors of polyion " as matrix) right of priority, it all is incorporated herein by reference at this.
The research or the exploitation of federal government's patronage
The part support of research of the present invention is the fund from National Institutes of Health (NIH) grant number GM071623 and EB002189.U.S. government enjoys interests to theme of the present invention.
Invention field
The present invention relates to the polyion sensor.The invention further relates to the film that is used to detect polyion (for example nucleoprotamine and heparin), and by this film being introduced this detection method in the electrochemical cell.Particularly the present invention relates to by making the polyion positive motion pass the method that this film detects polyion, wherein the motion of polyion is reversible, for use in re-using of this film.
Background of invention
In the past decade, along with the polymer film that adopts plasticising is used for the exploitation of the potentiometric sensor that the polyion macromolecule detects, new direction has appearred in the ion-selective electrode field.Early stage work in this field has advised containing the polymer membrane electrode of lipophilicity anionite, and it can detect the polyanion heparin.Referring to Ma, S.C, Yang, V.C, and Meyerhoff, M.E.Anal.Chem.1992,64,694.Heparin selective polymerisation thing membrane electrode further is described in U.S. Patent number 5,236,570 and U.S. Patent number 5,453,171 in.
Heparin be have mean charge for-70 and mean molecular weight be the Sulfated polysaccharide of 15,000 daltonian height.The molecular formula of a unit of heparin compound is provided below.
Heparin is at main operation and manipulation in vitro, as being used as anticoagulant in cardiac operation under direct vision, shunt operation and the dialysis.Yet in medical procedure, use excessive heparin to be harmful to, need be to the precise monitoring of heparin administration.The real-time monitoring of heparin concentration is useful especially for risk that prevents out hyperhematosis in surgical procedure and minimizing postoperative complication in blood.Activated clotting time is measured the commonsense method that (ACT) is heparin concentration in the estimation whole blood.Though this method is widely-used, it is non-specific and indirect, and the result can be subjected to the influence of many variablees.Compare with ACT, the heparin electrodes selective can directly detect heparin concentration in whole blood or plasma sample.
Similarly, also advised being used for the electrode of sensing polycation nucleoprotamine.Referring to Yun, J.H., Yun, J.H., Meyerhoff, M.E. and Yang, V.C.Anal Biochem.1995,224,212.During the polypeptide nucleoprotamine is generally used for and heparin activity (that is, promote solidify).Below illustrational nucleoprotamine be have mean charge for+20 polycation and its be rich in arginine residues.
The sulfonation base static of the alkaline guanidine radicals of nucleoprotamine and heparin is compound, makes that the anticoagulant active of heparin is invalid.Yet the excessive use of nucleoprotamine also is harmful to.For example, the use of nucleoprotamine usually causes disadvantageous Hemodynamics and hematology spinoff, has lung's blood platelet concurrently as oxygen consumption, the thrombopenia of hypertension, attenuating and separates and leukopenia.Therefore the nucleoprotamine concentration that can accurately detect and measure in biofluid such as blood is useful.
The reliable detection of nucleoprotamine can realize the careful administration of this reagent, has therefore avoided above-indicated relevant issues.In addition, also might be owing to detecting nucleoprotamine by come the heparin concentration in the working sample with nucleoprotamine titration sample by ion-selective electrode.This may be because above-mentioned specific Heparin-Protamine interacts.This type of effect also by people such as Ramamurthy at Clin.Chem.1998, be described in 606.
The viewed response of the specific membrane electrode of heparin well known in the prior art can not be explained according to traditional balance method.Because the high electric charge of these ions, for heparin and nucleoprotamine, nernst equation should obtain electrode function slope respectively for being lower than 1mV/ 10 years and 2mV/ 10 years.The quasi steady state model of explaining this unusual mechanism has been described subsequently.Referring to Fu, people such as B., Anal Chem.1994,66,2250.The response of measuring the polyion sensor of current potential is dynamic (dynamical) in nature.The powerful circulation of polyion has all appearred in mutually at aqueous solution and film, this be since polyion spontaneous be extracted in the polymer film and incident its with exchange from the water wettability ion in the film, this can cause the potential change in the presence of polyion.
Because when using the heparin specific membrane electrode of prior art, the extraction of polyion is an irreversible process, so observe the drift of forceful electric power position usually.After the relative short time with the contact of polyion solution, sensor begins to lose its response.The polyion of extraction must come by the reparation (as in concentrated sodium chloride solution) of sensor to remove mutually from film.Advised in the prior art that several different methods overcomes because the caused response loss of the lip-deep polyion concentration of film.The someone advises the mutual responsive current potential heparin sensor of pH, and wherein this sensor contains ion exchanger and charged H+ ionophore.According to this method, heparin is stripped and can be realized by regulating sample pH value.The another kind of method that overcomes sensor response loss is to use disposable sensor.
Therefore, although there is the selective extraction principle, still can not design reversible polyion sensor so far.Therefore, though the polyion sensor is very useful in critical nursing is used, their use is subjected to the sensor response restriction of loss fast.Disposable sensor can cause increasing cost, and need be by dividing other method taking-up sensor and readjust this sensor the validity that is quite time-consuming and has limited sensor unfriendly.Therefore, the sensor that has the detection polyion of completely reversibility is useful, wherein this reverse can be promptly, repeatedly and under need not to take out the situation of sensor in the independent solution carry out.
Summary of the invention
The invention provides the reversible electrochemical sensors that is used for polyion.This sensor comprises that potential response mechanism measures the concentration of polyion analyte, but the process that extraction and ion are stripped is subjected to galvanochemistry control.Spontaneous polyion extraction can contain the electrolytical film of the highly lipophilic with ion-exchange performance by use and suppress.If apply the fixedly continuous current pulse of duration at membrane electrode of the present invention two ends, but then can cause the counterextraction of polyion.Subsequently, remove polyion by applying constant reextraction current potential.The ability of this reextraction polyion makes sensor regeneration effectively, solved the problem that previously presented polyion sensor is faced, it has the tendency of drift and needed with the dense saline solution Long contact time so that strip polyion from sensing membrane before can carrying out another time measurement.
Containing the electrolytical film of lipophilicity can use with electrochemical cell, so that the polyion concentration in the continuous coverage sample solution and need not to take out electrode and readjust or change this electrode.Therefore, the titration of polyion such as heparin is possible.For example, be possible by the heparin concentration that adopts the nucleoprotamine titrimetry to measure in the whole blood sample.
According to an aspect of the present invention, provide a kind of polyion selective membrane that is used for electrochemical cell, wherein this film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group.Preferentially, a kind of selective in lipophilic cation component and the lipophilicity anionic group for specific polyion.The desirable especially polyion that is used to detect is heparin and nucleoprotamine according to the present invention.Comprise DNA (deoxyribonucleic acid) (DNA), ribonucleic (RNA), humic acid, carrageenan and other polyion macromolecule with detectable other polyion of film of the present invention.
As mentioned above, a kind of selective in electrolytical lipophilic cation component of this lipophilicity and the lipophilicity anionic group for special polyion.Therefore, in an embodiment of the invention, this lipophilicity electrolyte comprises nucleoprotamine lipophilicity anionic group selectively.Preferentially, in this embodiment, this lipophilicity electrolyte is four (dodecyl) ammonium 1,3-dinonyl naphthalene-4-sulfonate (TDDA-DNNS).Similarly, in another embodiment, this lipophilicity electrolyte comprises heparin lipophilic cation component selectively.Preferentially, in this embodiment, this lipophilicity electrolyte is dodine four (right-chlorphenyl) borate (DDG-TCIPB).
In yet another embodiment of the present invention, a kind of polyion selective membrane is provided, it comprises polymer film-forming material, plastifier and has the lipophilic cation component and the lipophilicity electrolyte of lipophilicity anionic group, wherein a kind of selective for specific polyion in this lipophilic cation and the lipophilicity anionic group.Preferentially, this polymer film-forming material is that Polyvinylchloride and this plastifier are 2-nitrobenzophenone Octyl Ether.
In according to another implementation of the invention, a kind of polyion selective membrane that is used for electrochemical cell is provided, wherein this film comprises that having a kind of potpourri is scattered in wherein many microporous hydrophobics property matrix, and this potpourri comprises plastifier and has the lipophilicity electrolyte of lipophilic cation component and lipophilicity anionic group.Preferably, selective for specific polyion one of in this lipophilic cation component and the lipophilicity anionic group.
In another aspect of the present invention, provide a kind of polyion selective membrane electrode that is used for electrochemical cell.In one embodiment, this polyion selective membrane electrode comprises shell, comprise reference solution in the enclosure and operationally place in the enclosure electrode, makes electrode contact with reference solution.In addition, according to this embodiment, the polyion selective membrane is set at an end of shell.Reference solution in this film and the shell contacts, and operationally places this film so that it touches the sample solution outside shell.This film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, wherein at least a selective for specific polyion in lipophilicity negative ion and the lipophilic cation component.
In another aspect of this invention, provide the method for polyion material concentration in a kind of sample solution.This method on the one hand can controllably, reversibly transport this polyion material and pass film aspect galvanochemistry according to the present invention.Therefore, this method can be used for the METHOD FOR CONTINUOUS DETERMINATION of the polyion material concentration in the sample solution (as biological sample).
An embodiment according to this method provides a kind of sample solution that wherein contains the polyion material.Preferably, this sample solution also comprises supporting electrolyte.This solution contacts with membrane electrode with the contrast electrode of electrical connection.The film of membrane electrode is made up of the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, at least a selective for the polyion material in this lipophilicity negative ion and the lipophilic cation component.When sample solution contacts with electrode, the circuit that comprises membrane electrode and sample solution is applied the extrinsic current pulse, the electric current that is applied orders about the polyion material and is transported to the film from sample solution.Preferably, this extrinsic current pulse has fixed duration.The potential response of measuring between membrane electrode and the contrast electrode can carry out during this current impulse.The concentration of polyion material can be calculated as the function of potential response then.
In this another embodiment on the one hand of the present invention, this method also comprises the external electrode current potential is put on membrane electrode and the contrast electrode, transports out from film thereby order about the polyion material.In this embodiment, this method can be used for reversible sensor, and wherein polyion is stripped, so this film is repaired for further use.
In according to this another embodiment of the present invention on the one hand, provide the method for the polyion material concentration in a kind of sample solution.This method may further comprise the steps:
A) provide a kind of sample solution that comprises polyion material and supporting electrolyte;
B) provide a kind of fuel cell arrangement, it comprises i) comprise the polyion selective membrane electrode of film, this film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, at least a selective in this lipophilicity anionic group and the lipophilic cation component wherein for specific polyion, ii) be electrically connected to the contrast electrode on this membrane electrode, iii) be electrically connected to the counter electrode on this membrane electrode, the control device that iv) is operably connected to the electrochemical apparatus on this electrode and v) is communicated with this electrochemical apparatus;
C) sample solution is contacted with the electrode of fuel cell arrangement;
D) fixedly the extrinsic current pulse of duration is applied to the circuit that comprises membrane electrode, counter electrode and sample solution;
E) measure potential response during this current impulse;
F) calculating is as the polyion material concentration of the function of this potential response; And
G) the external electrode current potential is applied to membrane electrode and contrast electrode, from film, transports out thereby order about the polyion material.One preferred embodiment in, repeating step d) to g) to obtain one or more additional measurements of polyion material concentration.
In according to a further aspect in the invention, a kind of fuel cell arrangement is provided, this device can be used for the polyion concentration in the sample solution.Device according to an embodiment comprises: the polyion selective membrane electrode that comprises a kind of film, this film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, wherein at least a selective for specific polyion in this lipophilicity anionic group and the lipophilic cation component; Be electrically connected to the contrast electrode on the membrane electrode; And be operably connected to electrochemical apparatus on membrane electrode and the contrast electrode.
In another embodiment of this respect according to the present invention, this fuel cell arrangement further comprises the counter electrode that is electrically connected on the membrane electrode.
In another embodiment of this respect according to the present invention, this fuel cell arrangement also comprises the controller equiment that is communicated with electrochemical apparatus.One preferred embodiment in, this controller equiment is computerized controller.Sort controller is convenient to the part or all of robotization of this fuel cell arrangement.
Another aspect of the present invention discloses a kind of sensor.This sensor comprises the electrode that is positioned at shell.A kind of film is disposed in this shell one end and contacts with shell sample solution outward, the polyion concentration in this film test sample solution, and the enzymatic activity that reduces in speed and this sample solution of this polyion concentration is in direct ratio.
This electrode can be the Ag/AgCl electrode.This film can have the 10mm of being about
2-100mm
2Surface area.On the other hand, this film can have the 20mm of being about
2-50mm
2Surface area.The average thickness that this film can have is about 10 μ m-1000 μ m.On the other hand, this film average thickness that can have is about 20 μ m-300 μ m.Polyion concentration can be the concentration of nucleoprotamine.The activity of enzyme can be tryptic activity.
In another aspect of this invention, disclose the method for polyion concentration in a kind of working sample solution, this method comprises the step that a kind of sample solution is provided.This method is further comprising the steps of: this sample solution is contacted with film, and wherein said film detects the polyion concentration in this sample solution, and the enzymatic activity that reduces in speed and the described sample solution of wherein said polyion concentration is in direct ratio.This sample solution can comprise biotic component, and this sample solution can comprise blood.
In another aspect of this invention, a kind of reversible fuel cell arrangement is disclosed.This cell apparatus comprises the polyion selective membrane electrode that contains film, and this film can be measured the polyion concentration in this sample solution, and the enzymatic activity that reduces in speed and the sample solution of this polyion concentration is in direct ratio.This cell apparatus also comprises and is used to apply the device that current potential cleans this film.Being used to apply the device that current potential cleans this film can be the external electrode current potential that applies between contrast electrode and polyion selective membrane electrode.
In another aspect of this invention, a kind of reversible electrochemical cell apparatus is disclosed.This cell apparatus comprises the polyion selective membrane electrode that contains film, and this film is measured the polyion concentration that solution has; This cell apparatus also is included between contrast electrode and the polyion selective membrane electrode and applies current potential to clean the device of this film.
In another aspect of this invention, a kind of sensor is disclosed, this sensor comprises the electrode that is positioned at shell, this sensor also comprise be arranged in this shell one end and with the outer contacted film of sample solution of shell, this film can detect enzymatic activity and the corresponding inhibitor activity in this sample solution.
This corresponding inhibitor activity can be a kind of activity in activity, Aprotinin and the soybean inhibitor of α 1-antiprotease inhibitor, alpha2-macroglobulin.Current potential among the present invention reduces can be depending on corresponding enzyme inhibitor concentration in the sample solution.
In another aspect of this invention, a kind of immunoassays are disclosed.These immunoassays can be measured analyte by adopting a kind of thing that serves as a mark in polyion and the enzyme.
Brief description of drawings
Fig. 1 is the synoptic diagram according to the fuel cell arrangement that comprises polyion selective membrane electrode of a preferred embodiment of the invention;
Fig. 2 be illustrate (A) according to polyion selective membrane electrode of the present invention and (B) ion-selective electrode of prior art at 0.1M NaCl with contain the figure of the electrode repeatability when being used alternatingly between the 0.1MNaCl of 10mg/L nucleoprotamine;
Fig. 3 illustrates to adopt a kind of measuring method of having introduced polyion selective membrane electrode of the present invention, and the solution of 0.1M NaCl solution and 0.1M NaCl and 10mg/L nucleoprotamine is carried out the electric current/time locus of pulse continuous current measurement and the figure of current potential/time locus;
Fig. 4 illustrates to adopt a kind of measuring method of having introduced polyion selective membrane electrode of the present invention, and the solution of 0.1M NaCl and the solution of 0.1M NaCl and 50mg/L nucleoprotamine are carried out the electric current/time locus of pulse continuous current measurement and the figure of current potential/time locus;
Fig. 5 utilizes the pulse continuous current to measure and adopts (A) according to polyion selective membrane electrode of the present invention and (B) correction graph of nucleoprotamine among the illustrated 0.1M NaCl of ion-selective electrode of prior art;
Fig. 6 shows the blank solution of 0.1M NaCl and when having under the 10mg/L nucleoprotamine cathode current that applies-2 μ A, stirs the figure for the influence of the response of polyion selective membrane electrode according to the present invention;
Fig. 7 shows does not have nucleoprotamine (lower curve) and when having added 25mg/L nucleoprotamine (upper curve), and under the cathode current of-2 μ A, sample pH value is for the figure of the influence of the response of polyion selective membrane electrode of the present invention;
Fig. 8 shows at NaCl, KCl, MgCl
2, CaCl
2Pure solution in and the solution of nucleoprotamine in 0.1M NaCl supporting electrolyte in, the correction graph of polyion selective membrane electrode according to the present invention;
Fig. 9 provides two figure, show respectively (A) in the presence of the supporting electrolyte (0.01M NaCl, 0.03M NaCl and 0.1M NaCl) of variable concentrations nucleoprotamine calibration curve and (B) be with or without under the situation of 0.1M KCl, KCl concentration is to the influence of nucleoprotamine calibration curve among the 0.1M NaCl;
Figure 10 shows the amplitude-time response figure of use polyion selective membrane electrode according to the present invention for the current potential of nucleoprotamine titration in the whole blood;
Figure 11 is a curve map, it shows (A) and adopts according to polyion selective membrane electrode of the present invention, utilize the titration of 1g/L nucleoprotamine solution to contain the whole blood sample of concentration for the heparin of 0mM, 0.25mM, 0.5mM, 1mM and 2mM, (B) adopt according to polyion selective membrane electrode of the present invention, for the corresponding calibration curve of Heparin-Protamine titration in the whole blood;
Figure 12 a shows the reaction rate (Δ E/ Δ t) of just adding potential change after the trypsase figure as the function of trypsinase concentration;
Figure 12 b shows the reaction rate (Δ C/ Δ t) of just adding nucleoprotamine concentration change after the trypsase figure as the function of trypsinase concentration;
Figure 13 a shows the reaction rate (Δ E/ Δ t) of just adding potential change after trypsase and the SI inhibitor figure as the function of SI inhibitor concentration; And
Figure 13 b shows the reaction rate (Δ E/ Δ t) of just adding nucleoprotamine concentration change after trypsase and the SI inhibitor figure as the function of SI inhibitor concentration.
The detailed description of embodiment
Now the present invention will be described more fully hereinafter.Yet the present invention can be embodied in many different forms and not will be understood that and only limit to the embodiment of illustrating at this; Or rather, provide these embodiments so that present disclosure satisfies the legal requiremnt that is suitable for.Employed singulative in instructions and claims " one ", " a kind of " and " being somebody's turn to do " comprise the indicated thing of plural number, unless clearly indicate in addition in context.
The invention provides a kind of reversible polyion sensor, it will combine with the follow-up reextraction that is used for handling again under instrument is controlled continuously by the polyion extraction process of mass transport limitation during measuring.The present invention uses and comprises the electrolytical polyion selective membrane of lipophilicity.The instrument control that film is passed in ion circulation make can be repeatedly with ion extractuin to the film neutralization ion of from film, stripping, obtain the high sensor response of reproducibility.In addition, promptly recover the ability of sensor film, in test process, it is moved serially so that the actual value of polyion concentration in the solution to be provided.
The current potential polyion selective sensor of this area previously known is a passsive sensor.This sensor has the lipophilic cation of containing exchanger molecule and (generally is expressed as general formula R
-Na
+) and the film of electrolyte aqueous solution.Phase boundary potential between the film in sample and this sensor can be determined according to equation (1):
α wherein
NaBe the activity of Na in Solution ion, [Na
+] be so-called on the phase boundary of film phase the free concentration and the E of sodion
0Expression is transferred to the free energy of film in mutually with sodium from water.Term R and T are respectively gas law constant and absolute temperature.In sample, do not have under the situation of nucleoprotamine (or other polycation), by ignoring ion pairing, determine Na ion concentration during film mutually, i.e. R by the total concentration of lipophilic cation exchanger
T, it can calculate according to equation (2).
[Na
+]
pb=R
T (2)
Therefore, the behavior of this film is similar to based on the sodium electrode of ion exchanger and can expect can this special response slope.
If nucleoprotamine is present in the aqueous solution, then will exist the nucleoprotamine kation logical with the high current of film in mutually on the surface simultaneously, form two stagnant diffusion layers.Because diffusion is a rate-limiting step in the layer that should stagnate of water, on the interface, can be observed the metastable state diffusion.The nucleoprotamine kation displaces sodium cation from the film phase boundary.This ion exchange process reduced film in mutually Na ion concentration and improved the current potential that is observed, as in equation (1), calculating.It is because the kation total concentration in the system must satisfy according to the described electroneutrality condition of equation (3) that this raising of the current potential that is observed may be interpreted as.
[Na
+]
pb=R
T-z[PA
z+]
pb (3)
[PA wherein
Z+]
PbBe the concentration that has the nucleoprotamine of electric charge z in the film phase boundary.Calculate according to equation (4) on the basis of considering the circulation of pseudostationary attitude, this concentration can be expressed as the function of nucleoprotamine volumetric concentration:
D wherein
m, D
Aq, δ
mAnd δ
AqBe respectively film mutually in, the nucleoprotamine coefficient of diffusion in the aqueous solution and in the gained thickness of diffusion layer.Equation (4) can be inserted into now in equation (3) and the equation (1), to obtain the nucleoprotamine response under the low concentration.The equation (5) of gained is provided below.
As confirmable in aforementioned calculation, if α
NaFix, then the phase boundary potential of this film demonstrates the direct response to nucleoprotamine.Therefore, under high nucleoprotamine concentration, near-this special response slope of energy to nucleoprotamine is replaced and be contemplated to sodion quantitatively from film.This quantitative displacement also can take place under rare nucleoprotamine solution, but needs time exposure (about 24 hours).The response slope of gained is too little, so that analytically of no use.
This spontaneous ion extractuin sensor can be undermined because of foregoing problems, is limited to disposable problem such as signal drift and most of sensor after long-time the use.Therefore, up to the present invention, just occurred a kind ofly being used to repair sensor so that continuous simple and easy, the reliable method of using.
With depend on the ion extractuin process in the above-mentioned passive type potentiometric sensor of spontaneous ion-exchange opposite, the present invention brings out ion extractuin by applying continuous current pulse electrochemical ground.In order to prevent spontaneous extraction, this film contains highly lipophilic electrolyte, and it generally can be according to general formula R
+R
-Define and do not have an intrinsic ion-exchange performance.Therefore, the initial concentration of nucleoprotamine or sodium cation is assumed to be zero in membrane body.The cathode current i that is applied has brought out the net flux of kation J on film phase direction.In order to simplify resulting equation, only can suppose sodium and nucleoprotamine ion can be extracted to film mutually in.Therefore, at current i and sodium flux J
NaAnd nucleoprotamine flux J
PABetween relation can calculate according to equation (6).
i=FAJ
Na+zFAJ
PA (6)
Wherein A is the membrane area that exposes.For the sake of simplicity, suppose linear concentration gradient and think that the na concn in the membrane body is zero that the sodium flux can be relevant with the concentration gradient across organic phase boundary, shown in the following equation (7).
If there is no nucleoprotamine, equation (6) and equation (7) can be inserted in the equation (1) and obtain equation as follows (8).
Fixedly the cathode current pulse of duration and intensity and constant potential reextraction pulse subsequently do not have sodion to keep membrane body, will obtain near-energy nernst electrode slope.If nucleoprotamine is present in the sample solution, then nucleoprotamine will be competed with sodion effectively in extraction process.Can be to be similar to the mode rewrite equation formula (6) of equation (7), shown in following equation (9).
Always greater than the flux of being kept alone by the polycation diffusion, equation (4) still effectively also can be inserted in the equation (9) flux that the electric current that present hypothesis is applied is forced.Therefore, sodium flux J
NaReduced, it has improved current potential according to equation (1).Equation (4) is inserted in the equation (9), solves [Na
+]
Pb, and insert in the equation (1), therefore obtained the nucleoprotamine response of the expectation under oligomeric ion concentration, it is provided in the following equation (10).
For the known potentiometric sensor of prior art, between the response of the nucleoprotamine shown in equation (10) and the equation (5), there are differences.Importantly, existing with the thickness of diffusion layer of continuous current mode controlling diaphragm in mutually, and also the constant potential film between pulse upgrades the repeatably δ that has guaranteed from a pulse to another pulse
mValue.Though embodiment provided by the present invention adopts the electric current of at first selecting to obtain maximum potential range, the present invention does not plan to be so limited.Therefore, the current impulse intensity that is applied can be used for regulating the measurement range of polyion response.Because be the electric current that is applied, rather than ion exchanger, define sodion and be extracted in the film that pulse timing controls in the current potential mode, the coefficient of diffusion of film in mutually do not influence the responding range of nucleoprotamine.This forms contrast with the prior art potentiometric sensor that is subjected to equation (5) domination, wherein known at sodium-nucleoprotamine the competitiveness extraction and the film coefficient of diffusion between have direct dependence.
Suitably utilize above background theories, now can easily understand advantage provided by the present invention.Particularly the invention provides a kind of polyion selective membrane that is used for electrochemical cell.In addition, this polyion selective membrane an integral part that can be the electrochemical cell electrode.But this polyion selective membrane and membrane electrode can be used for the inverse approach of the polyion material concentration in the sample solution.
Polyion selective membrane of the present invention is characterised in that and comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, wherein at least a selective for specific polyion in this lipophilicity anionic group and the lipophilic cation component.Term " lipophilicity " generally is understood that to be used for describing the material that fat is had affinity and has high lipid solubility.Lipophilicity is a kind of physicochemical property of describing the partition equilibrium of predetermined substance between water and immiscible organism.When water also existed, lipophilicity can further be described to a kind of material and be dissolved in the ability of lipid in mutually.This relation (that is partition factor) can be defined as the equilibrium constant of material concentration in the two-phase.Comparative standard generally is a 1-octanol/water partition factor.Can come calculation of distribution coefficient according to equation shown below (11).
According to equation (11), can expect that showing high oil loving molecule preferentially demonstrates dissolubility in lipid rather than in the water.
Being used for measuring a lipophilic functional test is the container that compound to be tested is placed on the potpourri that has held 50% water and 50% lipid (as the 1-octanol).The compound of being concerned about can be placed in the container, and can apply mixing force and be distributed in the two-phase to force this compound.Container is left standstill so that this compound reaches concentration balance between each phase.Can measure this compound concentration in each phase then, and this concentration can be used for equation (11) to determine lipophilicity.
Computer software also can be used to determine the lipophilicity of material.Determine that a lipophilic computer program example is at http: the last online ALOGPS program that gets of // 146.107.217.178/lab/alogps.Relevant lipophilic principle is also by Bakker, E.and Pretsch, E, at " Lipophilicity of tetraphenylborate derivatives as anionic sites in neutralcarrier-based solvent polymeric membranes and the lifetime ofcorresponding ion-selective electrochemical and optical sensors " AnalyticaChimica Acta, 1995,309,7-17, in discuss, at this its full content is incorporated herein by reference.
Usually, have compound greater than the P value of 100,000 calculating and be considered to highly lipophilic, and be useful therefore according to the present invention.Yet, can estimate usually to use to have even the compound of higher P value can cause sensor life-time to increase.Therefore, the P value of preferred lipophilic compound used according to the invention is greater than 100,000, more preferably greater than 1,000,000, and most preferably greater than 10,000,000.
The known polyion selective membrane of prior art comprises lipophilicity electrolyte and anti-lotus kation (that is R, of water wettability
-Na
+).According to the present invention, the water wettability gegenion is replaced by the lipophilicity gegenion.Therefore, polyion selective membrane of the present invention comprises lipophilicity electrolyte (that is R, with lipophilic cation component and lipophilicity anionic group
-R
+).By using two kinds of lipophilicity electrolyte, the lipophilicity gegenion no longer spontaneously with sample in measured polyion mass exchange.Preferably, selective for specific polyion one of in this lipophilicity anionic group and the lipophilic cation component, make this polyion detected easily.Want the non-limitative example of the specific polyion that detects to comprise nucleoprotamine, heparin, humic acid, carrageenan, DNA, ribonucleic and other polyion macromolecule.
In an embodiment of the invention, the electrolytical lipophilicity anionic group of lipophilicity is selective for nucleoprotamine.The nucleoprotamine selectivity of this lipophilicity anionic group depends on this anionic functional group.Nucleoprotamine contains alkaline guanidine radicals (that is arginine residues).Therefore, for selective to nucleoprotamine, this lipophilicity negative ion must comprise the functional group that can form ion pair with the guanidine radicals of nucleoprotamine.One preferred embodiment in, adopt to have carboxyl (COOH), sulfo group (SO
3H) or sulfate (OSO
3H) lipophilicity negative ion is used for the selectivity of nucleoprotamine.In a particularly preferred embodiment, the electrolytical lipophilicity anionic group of lipophilicity is selected from 1,3-dinonyl naphthalene-4-sulfonate, 2,6 dinonyl naphthalene-4-sulfonate, dodecyl benzene sulfonate and 3,9-diethyl-6-tridecyl sulfate.The chemical formula of these compounds is as follows.
1,3-dinonyl naphthalene-4-sulfonate
2,6 dinonyl naphthalene-4-sulfonate
Dodecyl benzene sulfonate
3,9-diethyl-6-tridecyl sulfate
As mentioned above, when the water wettability gegenion of known membrane electrolyte is replaced by the second lipophilicity electrolyte, prevented that ion is extracted into the polyion selective membrane from sample is spontaneous.Usually, the water wettability gegenion is a sodium, because sodium is the gegenion of the maximum that exists in the sample solution.Replace sodion by chemosynthesis with the lipophilicity gegenion.When the polyion chosen anion is selective for nucleoprotamine, any lipophilicity quaternary ammonium cation that can estimate to have about 4 to about 16 alkyl side arm chain length will be suitable gegenion.
One preferred embodiment in, with the water wettability gegenion of nucleoprotamine selectivity lipophilicity negative ion pairing be the kation that is selected from four (dodecyl) ammonium, three (dodecyl) ammonium methyls and dodecyl trimethyl ammonium.These cationic chemical formulas are as follows.
Four (dodecyl) ammonium
Three (dodecyl) ammonium methyl
Dodecyl trimethyl ammonium
According to above description, might select lipophilicity negative ion and the cationic combination of the anti-lotus of lipophilicity selectively to suppress spontaneous ion-exchange with sample solution to nucleoprotamine about the lipophilicity ion.Therefore, above nucleoprotamine chosen anion that provides and cationic any may the combination of anti-lotus can be provided spendable nucleoprotamine-selectivity lipophilicity electrolyte according to the present invention.According to a preferred implementation, being used for optionally from the lipophilicity electrolyte of solution extraction nucleoprotamine is four (dodecyl) ammonium 1,3-dinonyl naphthalene-4-sulfonate (TDDA-DNNS).
In according to another implementation of the invention, the lipophilicity electrolyte comprises heparin lipophilic cation component selectively.The heparin selectivity of cationic components depends on the functional group of this compound.Heparin contains sulfo group and carboxyl.Therefore, for selective to heparin, suitable kation must contain one or more groups that can form ion pair with the sulfo group and the carboxyl of heparin.Being particularly conducive to heparin is provided optionally is guanidine radicals.In addition, long aliphatic lateral chain or the aromatic ring of the heparin (as film according to the present invention) by neighboring cation piles up and stabilized from sample extraction to organic sensing phase.Therefore, the kation with highly lipophilic can have chain length and is about on the aliphatic chain of 4-18 carbon atom and/or suitable aromatic functionality and prepares by one or more guanidine radicals are connected to.One preferred embodiment in, the electrolytical lipophilic cation component of lipophilicity is selected from dodine and N, N '-1,10-decane two base two (guanidine).These cationic chemical formulas are as follows.
Dodine
N, N '-1,10-decane two bases two (guanidine)
In addition, when the water wettability gegenion is replaced by the second lipophilicity electrolyte, prevented spontaneous extraction ion from sample.Usually, the negative ion of maximum in testing liquid, chlorion is replaced by the lipophilicity negative ion through chemosynthesis.The one group of negative ion that can be used as gegenion according to this embodiment is the tetraphenyl borate salts derivant, as three kinds of borates that provide below.
Tetraphenyl borate salts (TPB)
Four (right-chlorphenyl) borates (CIPB)
Four (3, two (trifluoromethyl) phenyl of 5-) borate (TFPB)
The suitable negative ion of another combination is lipophilicity (fully halogenated or alkylating) 12 carboranes.12 carborane radicals are in the icosahedron carborane anion, have chemical formula CB when it is in complete unsubstituted form
11H
12 -12 carboranes of halogenation are as the 1-H-CB according to the present invention
11Cl
11, 1-H-CB
11Br
11And 1-H-CB
11I
11Be be particularly useful and more fully by Peper, S. wait the people, be described in " Ion-pairing Ability, Chemical Stability, and SelectivityBehavior of Halogenated Dodecacarborane Cation Exchangers in NeutralCarrier-Based Ion-Selective Electrodes; " Analytical Chemistry, (2003) 75 (9), 2131-2139 all is incorporated herein by reference it.Also useful according to the present invention is alkylating 12 carboranes, and wherein aforesaid halogen group is replaced by various alkyl.One preferred embodiment in, with heparin optionally the water wettability gegenion of lipophilic cation pairing be four (right-chlorphenyl) borate anion.
According to above description, might select lipophilic cation and the anionic combination of the anti-lotus of lipophilicity selectively to suppress spontaneous ion-exchange with sample solution to heparin about the lipophilicity ion.Therefore, above heparin selectivity kation that provides and anionic any may the combination of anti-lotus can be provided spendable heparin-selectivity lipophilicity electrolyte according to the present invention.According to a preferred implementation, being used for from the lipophilicity electrolyte of solution selective extraction heparin is dodine four (right-chlorphenyl) borate (DDG-TCIPB).
Use the principle of above-mentioned outline, also might determine the specific polyion except that nucleoprotamine or heparin is selectively had the lipophilicity electrolyte of lipophilic cation component or lipophilicity anionic group.Therefore, containing the electrolytical film of this type of lipophilicity also is included in the present invention.
The electrolytical amount of lipophilicity that exists in film according to the present invention can change according to the physical property of this film, and it can limit the solubleness of salt in film.Preferably, the electrolytical amount of lipophilicity is based on about 1-15wt% of film general assembly (TW).More preferably, the electrolytical amount of lipophilicity is the about 5-12wt% that accounts for the film general assembly (TW).One preferred embodiment in, the electrolytical amount of lipophilicity is the about 10wt% that accounts for the film general assembly (TW).
Except that the lipophilicity electrolyte, film according to the present invention may further include one or more plastifier.Plastifier has promoted mixing uniformity and has helped to control the flux of polyion from sample solution to film surface and membrane body.Various plastifier can be used in the film of the present invention, it includes but not limited to be selected from following plastifier: 2-nitrobenzophenone Octyl Ether, dioctyl phthalate, di-n-octyl sebacate, dioctyl adipate, dibutyl sebacate, dibutyl phthalate, 1-decyl alcohol, 5-phenyl-1-amylalcohol, benzohydrol 3,3 ', 4,4 '-tetrabasic carboxylic acid four (undecyl) ester, benzylic ether, phosphonic acids dioctyl phenylester, tri-2-ethylhexyl phosphate and 2-nitrobenzophenone Octyl Ether.In according to a preferred embodiment of the present invention, the plastifier that adopts in the film is a 2-nitrobenzophenone Octyl Ether (NPOE).
Usually preferably, film of the present invention except that lipophilicity electrolyte and plastifier, also comprises the host material that forms material as the body of film.The multiple matrix that is used to form permeable membrane is well known by persons skilled in the art, and the present invention is intended to comprise all this type of matrix.
In one embodiment, host material is a polymer film-forming material.Polymer film-forming material according to this embodiment can be any polymeric material compatible with the plastifier chemistry with the lipophilicity electrolyte.In addition, this polymeric material should be able to be shaped as film, as casting by solvent streams.As nonrestrictive example, according to the present invention can with polymeric material comprise Polyvinylchloride, polyurethane, cellulose triacetate, polyvinyl alcohol (PVA), silicon rubber, with and multipolymer and terpolymer.One preferred embodiment in, this polymer film-forming material is a Polyvinylchloride.
In an embodiment of the invention, the polyion selective membrane comprises the lipophilicity electrolyte of about 1-15wt%.Further comprise the polymer film-forming material of about 28-49.5wt% and the plastifier of about 42.5-66wt% (total weight is that the general assembly (TW) with film is a benchmark) according to the film of this embodiment.Preferably, the ratio of polymer film-forming material and plastifier existence is about 1: 1-1: 2 (by weight).
One preferred embodiment in, the polyion selective membrane comprises four (dodecyl) ammonium 1 of about 10wt%, the 2-nitrobenzophenone Octyl Ether of the Polyvinylchloride of 3-dinonyl naphthalene-4-sulfonate, about 30wt% and about 60wt% (total weight is that the general assembly (TW) with film is a benchmark).
Can be suitable for curtain coating by employing according to the polyion selective membrane of one of above embodiment becomes the organic solvent of film such as tetrahydrofuran (THF) to carry out solvent streams to cast and prepare.Preferably, with polymer film-forming material, plastifier and lipophilicity preparation of electrolyte be homogeneous solution in the solvent.Solution casting can be become film then.In case be prepared as film, this film can be cut into the size of any regulation so that be used for the polyion sensor subsequently.Not to be configured as film, but this coating solution can be applied on base material such as the electrode, and it is dry on electrode, thus directly on electrode, form film.
According to an embodiment of the invention, at least a in lipophilicity anionic group and the lipophilic cation component can be covalently bound in the backbone structure of polymer film-forming material.For example utilize copolyreaction or some other suitable chemical reaction form of vinyl bonds anionic group can be connected on the polymer chain.In addition, the lipophilic cation or the anionic group that can be connected on the polymer architecture can be polyion optional ingredient or gegenion component.
In another embodiment, host material is the hydrophobic base of porous.According to this embodiment, plastifier and lipophilicity electrolyte form potpourri, are distributed to then on many microporous hydrophobics property matrix, and wherein the electrolytical potpourri of plastifier and lipophilicity is inhaled among the hole of matrix, and makes its curing.Process for use in the polyion sensor wherein being dispersed with the electrolytical many microporous hydrophobics property matrix of plastifier and lipophilicity then.According to many microporous hydrophobics property matrix of an embodiment of the present invention can be selected from tygon, polypropylene, nylon, polyvinylidene fluoride, polycarbonate, teflon, acrylic copolymer, polyethersulfone, with and multipolymer and terpolymer.According to a preferred implementation, the hydrophobic base of this porous is a tygon.What be preferably used as many microporous hydrophobics property matrix especially is can be from Celgard, Inc., the Celgard that Charlotte, N.C obtain (R) film.Celgard (R) film is the polyethylene based film that can be used as flat sheet membrane and hollow-fibre membrane.
In a preferred embodiment of the present invention, the polyion selective membrane comprises the porous hydrophobic matrix that has contacted with the potpourri that comprises about 1-15wt% lipophilicity electrolyte and about 85-99wt% plastifier, described lipophilicity electrolyte comprises lipophilic cation component and lipophilicity anionic group, and percentage by weight is based on the general assembly (TW) of potpourri.
The present invention further provides a kind of polyion selective membrane electrode that can be used for electrochemical cell.In an embodiment of the invention, polyion selective membrane electrode comprises shell, comprise in the enclosure reference solution and location electrode in the enclosure operationally, and electrode is contacted with reference solution.In addition, according to this embodiment, the polyion selective membrane is arranged on an end of shell.Reference solution in this film and the shell contacts, and this film is operationally located so that it touches the sample solution outside shell.As mentioned above, this film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, wherein at least a selective for specific polyion in lipophilicity anionic group and the lipophilic cation component.
This embodiment according to the present invention can adopt any normal electrode, as long as this electrode can be introduced aforesaid polyion selective membrane.In a particularly preferred embodiment of the present invention, membrane electrode comprises and is introduced in normal electrode such as Philips electrode body (IS-561, GlasblsereiMoller, Zurich, Switzerland) the polyion selective membrane in.
The reference solution that adopts in the electrode shell can be those skilled in the art's known spendable any electrolyte solutions usually.One preferred embodiment in, this electrolyte solution is a sodium chloride solution, particularly 1M NaCl solution.In addition, electrode itself can be any kind electrode that can be used in the electrochemical cell with current potential as described below and current value.Useful especially is the Ag/AgCl electrode.
According to a preferred implementation, the polyion selective membrane of introducing in the membrane electrode is selective to nucleoprotamine.Preferably, according to this embodiment, the lipophilicity electrolyte that is used for the polyion selective membrane is TDDA-DNNS.
When using with membrane electrode, preferably the surface area of polyion selective membrane is about 10mm
2-100mm
2More preferably surface area is about 20mm
2-50mm
2In order to reach such surface area, film preparation can be as mentioned above, and film is cut into required size (for example using cork borer), so that match with electrode.More preferably, the average thickness of polyion selective membrane is about 10 μ m-1000 μ m, is more preferably 20 μ m-300 μ m.
The invention further relates to a kind of fuel cell arrangement.In one embodiment, this fuel cell arrangement comprise foregoing polyion selective membrane electrode, be electrically connected to the contrast electrode on the membrane electrode and be operably connected to membrane electrode and contrast electrode on electrochemical apparatus.
An embodiment according to fuel cell arrangement of the present invention is provided among Fig. 1, the figure shows the fuel cell arrangement 5 that can be used for polyion material in the measuring samples.Fig. 1 shows polyion selective membrane electrode 10, contrast electrode 30 and operationally is positioned over counter electrode 50 in the test sample vessel 60 that sample solution 65 has been housed.Membrane electrode 10 comprises electrode shell 15, reference solution 17 and reference electrode wire 21.What be arranged in electrode shell 15 1 ends is according to polyion selective membrane 25 of the present invention.Contrast electrode 30 as shown in Figure 1 is binode electrodes, though do not deviating under the present invention, the contrast electrode of other type also can be used.Contrast electrode 30 comprises shell 33, inner casing 36, shell reference solution 39, inner casing reference solution 41 and reference electrode wire 43.
As shown in Figure 1, polyion selective membrane electrode 10, contrast electrode 30 and counter electrode 50 are operably connected on the electrochemical apparatus 75 separately, and it further is communicated with control device 90.Electrochemical apparatus 75 is preferably continuous current-potentiostat.Therefore, electrochemical apparatus can be with the Current Control by electrochemical cell in predetermined value and also can be with the control of Electric potentials between working electrode (for example, polyion selective membrane electrode 10) and the contrast electrode 30 in predetermined value.During a function, electrochemical apparatus 75 can be forced necessary any electric current to keep required current potential between working electrode (for example, polyion selective membrane electrode 10) and counter electrode 50 after execution.In a particularly preferred embodiment, electrochemical apparatus 75 is two constant potentials, as from PineInstruments (Grove City, Pa.) available AFCBPl Bipotentiostat.
The invention further relates to the method for polyion material concentration in a kind of sample solution.This method generally includes following steps: the sample solution that comprises polyion material and supporting electrolyte a) is provided; B) sample solution is contacted with the polyion selective membrane electrode with film, this film comprises the lipophilicity electrolyte with lipophilic cation component and lipophilicity anionic group, wherein at least a selective for this polyion material in this lipophilicity anionic group and the lipophilic cation component; C) sample is contacted with contrast electrode, polyion selective membrane electrode and contrast electrode are electrically connected; D) circuit that comprises polyion selective membrane electrode and sample solution is applied the fixedly extrinsic current pulse of duration, transfer to this film from sample solution thereby order about the polyion material; E) measure the potential response between polyion selective membrane electrode and contrast electrode during this current impulse; And f) calculating is as this polyion material concentration of the function of potential response.
The preferred fixedly extrinsic current pulse of duration has applied about 0.1 second to about 2 seconds duration.The general potential response that does not need to measure the full duration of the current impulse that applies.But preferably measure potential response for the only part in applying extrinsic current duration of pulse.In a particularly preferred embodiment, potential response is current impulse outside and fixedly measures during last about 100 milliseconds of duration.
The potential value of measuring in the above method depends on the polyion type that exists in the sample.For example, if there is kation,, then cathode current (bearing) is put on this battery as nucleoprotamine.When applying electric current, the current potential that records becomes bigger negative value.When having negative ion such as heparin, anode current (just) is put on this battery.When applying electric current, the current potential that records become bigger on the occasion of.
Generally include polyion selective membrane electrode and sample solution although be applied in the circuit of extrinsic current, this circuit also can comprise one or more other assemblies of electrochemical cell.For example, in one embodiment according to the present invention, this circuit also comprises counter electrode.This embodiment will comprise as usual the electro-chemical systems that is called " three electrodes " electrochemical cell.In addition, in another embodiment, this circuit also comprises contrast electrode.This embodiment comprises as usual the electro-chemical systems that is called " two electrodes " electrochemical cell.Usually preferred three-electrode system is to avoid the occurring contrast electrode deterioration when extrinsic current is applied on these electrodes.
Usually can estimate that the current potential absolute value of measuring in the above method will reduce as time passes, this stably increases owing to thickness of diffusion layer in the film.As mentioned above, when the existing of test polycation such as nucleoprotamine, apply cathode current and observe negative potential.When nucleoprotamine (or another kind of polycation) when being present in the sample, measured current potential is than the situation that does not have polycation, obviously be bigger on the occasion of.On the contrary, when test during the existing of polyanion, apply anode current and observed current potential is positive.If heparin (or another kind of polyanion) can be estimated measured current potential than the situation that does not have polyanion when being present in the sample, obviously is bigger negative value.In two kinds of situations, to the corrigendum or more the mobile of negative charge be that polyion is extracted into the indication in the film from sample solution.Behind time enough, because polyion gathering in film, measurement begins to interrupt.
In a preferred embodiment of the present invention, this film is restored.According to this embodiment, above method further comprises the external electrode current potential is put on polyion selective membrane electrode and the contrast electrode, is shifted out from the film transfer thereby order about the polyion material.In case this film is by the polyion of having stripped effectively, this polyion selective membrane electrode can be used for the polyion of sample solution once more.By applying the pulse train that comprises extrinsic current pulse and volta potential pulse subsequently repeatedly, make continuous, the reversible detection of polyion material become possibility.
Preferably, the external electrode current potential that is applied for reextraction polyion from film is a baseline potential.The baseline potential value can change along with the symmetry of electrochemical cell.For example, in one embodiment, membrane electrode adopts identical electrode and has to sample solution with contrast electrode forms similar interior reference solution.In this preferred implementation, baseline potential is 0V.Also imagined other embodiment, wherein electrode is demonstrating lower symmetry in varying degrees.In these other embodiments, can estimate that baseline potential will begin to change from 0V.By disconnecting electrochemical apparatus (referring to Fig. 1), and with high-impedance voltmeter it is replaced with the zero current current potential of measuring between membrane electrode and the contrast electrode and can measure best baseline potential.
For the polyion of stripping from film effectively, the fixedly duration of the duration that preferably applies volta potential than extrinsic current pulse is about 10-20 doubly.
According to following experimental example the more embodiment of the present invention can be described more clearly.
The present invention is the polyion in the test sample solution on the other hand, nucleoprotamine for example, and this detects based on itself and for example tryptic direct relation of enzymatic activity.If endonuclease capable makes polyion be divided into short section, then the activity of this enzyme can be recorded, because these short sections can not be detected well by the polyion sensor usually.The Electrochemical Detection that is similar to a kind of detection disclosed by the invention has the advantage that is better than the spectrophotometric method of enzymatic activity in conventional opaque, the coloured or muddy sample of detection.
A kind of embodiment of this respect of the present invention is the purposes that trypsase is used for nucleoprotamine.Trypsase is the enzyme in basic amino acid lysine and arginic carboxyl side place scinderin matter.Because nucleoprotamine is rich in arginine residues, trypsase will be at these contact place cutting nucleoprotamine.When adopting electrochemical appliance disclosed by the invention and nucleoprotamine sensor, can find that the initial rate and the tryptic activity of nucleoprotamine decomposition is in direct ratio.Sensor signal potential change speed as the function of time is owing to the digestion of trypsase to nucleoprotamine.This relation can expand to various polyions and corresponding enzyme thereof.
Another embodiment of the present invention is to apply current potential to clean film it to be reused in enzymatic activity, polyion concentration and inhibitor activity detect.Should be noted that and utilize the present invention can detect other biology and chemical activity.
In addition, the present invention can be used for the inhibitor activity in the test sample solution.Enzyme inhibitor combines with enzyme and has reduced enzyme reaction speed effectively.The concentration of enzyme inhibitor in the sample solution is depended in the reduction of initial potential after the potpourri that adds enzyme and enzyme inhibitor.
A kind of embodiment of this respect of the present invention is the inhibitor that is used for enzyme trypsase and following a kind of corresponding enzyme: α 1-antiprotease inhibitor, alpha2-macroglobulin, Aprotinin and soybean inhibitor.
In another aspect of the invention, potentiometric titration polyion sensitive electrode can find application in no separating immune is measured.These immunoassays can adopt the polyion of mark or the relevant enzyme thing that serves as a mark to detect analyte, and this analyte can be used as label through free analyte with have in the competitive bidding of mark analyte of antibody.
Experiment
Can illustrate the present invention more fully by following embodiment, listing these embodiment is to think to limit the present invention in order to demonstrate the invention and not.Except as otherwise noted, all percentages is meant that with polyion selective membrane general assembly (TW) be the percentage by weight of benchmark.
The preparation of nucleoprotamine-selective membrane
Test comprising the sensor capability that is ready to use in the polyion selective membrane of the present invention in the electrochemical cell.The polycation selective membrane is mixed with for the polycation nucleoprotamine selective especially.The film that forms is for to have 10wt% TDDA-DNNS in 2: 1 weight ratio potpourris of 2-nitrobenzophenone Octyl Ether and Polyvinylchloride.By adopting THF to prepare this film as the solvent streams casting of solvent.Make the potpourri drying and forming-film, made nucleoprotamine-selective membrane that thickness is about 200 μ m.With diameter be the cork borer of 6mm cut this film with preparation for the film that is incorporated in the electrode.
The preparation of nucleoprotamine-selective membrane electrode
Nucleoprotamine-the selective membrane that will prepare in embodiment 1 is incorporated in the electrode.Electrode comprises interior reference solution and the Ag/AgCl electrode wires of Philips electrode body (IS-561), 0.1M NaCl.Nucleoprotamine-selective membrane electrode before using, is regulated whole night in the solution identical with interior reference solution in experiment.
Prepare one group of 10 identical electrode as mentioned above, and before the experiment of reality is used, in 0.1M NaCl solution, test its denseness.Test be presented between given electric current bottom electrode in 0 to-10 μ A scope changeability for+/-7mV (standard deviation).
The also tested reversibility of estimating of membrane electrode.Film is exposed in two kinds of independent solution repeatedly a kind of 0.1M NaCl that contains, a kind of 0.1M NaCl and 10mg/L nucleoprotamine of containing.Also adopt the ion-selective electrode of prior art to carry out identical test.The results are shown among Fig. 2 of test, nucleoprotamine wherein of the present invention-electrodes selective film is shown in the curve A, and the electrode of prior art is shown in the curve B.In two curves, as seen, when having nucleoprotamine, observe higher current potential.In curve A, repeatably potential measurement have+/-variation of 1mV.It changes greater than 50mV in 5 cycles less yet but be presented in curve B.
There is and do not have the time-measuring electric potential response of the sample of nucleoprotamine
Be produced on and do not have a chronopotentiogram among the 0.1M NaCl of nucleoprotamine.Utilize nucleoprotamine-selective membrane electrode of describing among the embodiment 2 to set up electrochemical cell as shown in fig. 1.Contrast electrode is to have the electrolytical binode Ag/AgCl of 1M LiOAc bridge electrode.Counter electrode is a platinum filament.
The voltammetry experiment is AFCBP1Bipotentiostat (the Pine Inst. that utilizes by the control of PCI-MIO-16E4 interface board, Grove City, Pa.) and 5.0 softwares of the LabVIEW on the macintosh computer (National Instruments, Austin Tex.) carry out.Before experiment, convert the first electrode output function of double potentiostat (K1) under the control of second working electrode (K2) output constant potential Current Control.In order to apply current impulse, the analog switch that working electrode is controlled via external software is connected to K1 output.When between current impulse, applying the baseline current potential, working electrode is connected to K2 output.
In the chronopotentiometric titration experiment, the continuous current pulse (1 second duration) that is at every turn applying-3 μ A is the constant potential pulse (10 seconds duration) under 0V afterwards.The sampling current potential of gained (its expression sensor response) is the mean value during the last 100ms of each current impulse.All experiment is carried out under laboratory environment temperature (21.5 ± 0.5 ℃).The fiducial interval level of calculating is 95%.
Experiment is carried out in two samples.First sample only contains 0.1M NaCl, and second sample contains 0.1M NaCl and concentration is the nucleoprotamine (PA) of 10mg/L.-3 μ A cathode currents that applied cause nucleoprotamine to be extracted in the film, compare with the sample that does not have nucleoprotamine, and are significantly different for the viewed current potential of the sample that nucleoprotamine is arranged.Electric current-the time locus and the current potential-time locus of chronopotentiometric titration experiment are provided among Fig. 3.
There is and do not have the more chronopotentiometric titration response of the sample of the nucleoprotamine of high-load
Adopt and to be manufactured with the identical test unit that in embodiment 2, is provided and not have second chronopotentiogram among the 0.1M NaCl of nucleoprotamine.In the chronopotentiometric titration experiment, the continuous current pulse (1 second duration) that at every turn applies-2 μ A is the constant potential pulse (15 seconds duration) under 0V afterwards.The sampling current potential of gained (its expression sensor response) is the mean value during the last 100ms of each current impulse.All experiment is carried out under laboratory environment temperature (21.5 ± 0.5 ℃).The fiducial interval level of calculating is 95%.
In two samples, experimentize once more.First sample only contains 0.1M NaCl, and second sample contains 0.1M NaCl and concentration is the nucleoprotamine of 50mg/L..-3 μ A cathode currents that applied cause nucleoprotamine is extracted in the film, compare with the sample that does not have nucleoprotamine, and are significantly different for the viewed current potential of the sample that nucleoprotamine is arranged.Electric current-the time locus and the current potential-time locus of chronopotentiometric titration experiment are provided among Fig. 4.
During the constant potential rest pulse, can be observed ion antidiffusion from film.When nucleoprotamine was present in the sample, this diffusion was more slowly, had shown the difference on dispersal behavior between sodium and nucleoprotamine ion.When asking current integration on the whole rest pulse at 15 seconds, the electric charge that calculates is corresponding to 90% of the electric charge that applies during this current impulse.
The calibration curve that compares nucleoprotamine of the present invention-selective membrane electrode and prior art polyion-selective membrane for nucleoprotamine
Take a sample by the electrogram that applies repeatedly when finishing, make continuous, the reversible detection of nucleoprotamine become possibility in the pulse train as shown in Fig. 3 and Fig. 4 and to each current impulse.Therefore, might obtain the nucleoprotamine calibration curve.
Utilize said method in embodiment 3 and 4 can be in 0.1M NaCl the time locus of nucleoprotamine calibration curve.Utilize the ion-selective electrode of the nucleoprotamine described in the embodiment 2-selective membrane electrode and prior art can obtain some curves.The contrast of two kinds of curves is provided among Fig. 5, wherein adopt the curve of nucleoprotamine of the present invention-selective membrane electrode gained to be shown in the curve A, and the curve of prior art electrode is shown in the curve B.It is poor that observed forceful electric power position drift comes from the film side thickness of diffusion layer control in curve B.The nucleoprotamine concentration (mg/L) of logarithm is indicated on the track.
Stirring is for the influence of sensor response
For the potentiometric titration polyion sensor of prior art, known observed current potential can be subjected to the strong influence of sample stir speed (S.S.), and it has changed moisture diffusion layer and has therefore changed the polyion flux that enters into film.In fact, recent achievement the is verified definite relation between measurement range and rotating speed in the electrode assembly of rotation.To stir the response that can how to influence in order investigating in the continuous current pulse test, in agitating solution not and under the stir speed (S.S.) at 100rpm, to measure current potential according to polyion selective membrane electrode of the present invention.Both contrasts are provided among Fig. 6.
Opposite with the potentiometric titration result who adopts heparin response film (wherein sample stirs the potential change that stops to have caused about 20mV suddenly), the response of pulse continuous current sensor of the present invention does not have to show the appreciable impact that is subjected to stirring rate.Stir and not the potential difference (PD) between the stirred sample surpass 2-3mV.
The pH value is for the influence of sensor response
Though it is to work in 7.4 the whole blood that this nucleoprotamine sensor is intended to the physiological pH value, also investigated of the influence of pH value for the sensor response.Fig. 7 provides current potential observed under the cathode current of-2 μ A.Following track is for the blank solution that comprises 0.1M NaCl, 6.6mmol citric acid, 11mmol boric acid and 10mmol phosphoric acid, viewed current potential under the pH value that adopts 1M NaOH to regulate.Last track is for the viewed current potential of the same solution that contains the 25mg/L nucleoprotamine in sample.Because nucleoprotamine concentration height, the difference of two kinds of current potentials can be thought maximum sensor response or electrochemical window in 0.1M NaCl.
The film selectivity
The selectivity of film is to measure by the independent calibration curve of the chloride salt of record sodium, potassium, calcium and magnesium pH 7.4 times.The curve of current potential-salinity logarithm is provided among Fig. 8.The gained selectivity factor with reported about the DNNS base ISE film that does not have the additional ions carrier in the past those are very consistent.The whole slopes of discovery in the 0.001M-0.1M concentration range are super slightly (slightlysuper)-Nemstian (70-72mV), and it departs from selectivity factor to a certain extent.This slope might explain that by the contribution of ion migration on the membrane interface this equation also was not studied according to the Nernst-Plank equation in the theoretical model of simplifying.About 10
4The sudden change current potential of M rises to and comes from the lip-deep consumption process of film.Nucleoprotamine calibration curve in 0.1M NaCl also is shown among Fig. 8.Higher electrogram shows, compares with whole other kations of testing, has greatly preferred property for this film of nucleoprotamine.
The influence of supporting electrolyte concentration
Can estimate that supporting electrolyte concentration can influence the nucleoprotamine response curve, because this response theory is based on the competitiveness extraction between polyion and the sodion.For example, can haggle over low sodium background concentration in advance and can produce bigger potential range (referring to equation 10), and also may cause this response to be transformed into lower nucleoprotamine concentration (equation 10) for the nucleoprotamine response.Fig. 9 A has shown the experiment nucleoprotamine calibration curve under three kinds of sodium chloride concentrations (10mM, 30mM and 100mM).The nucleoprotamine potential range descends along with increasing of NaCl concentration.
Potassium is shown among Fig. 9 B for the trickle influence of nucleoprotamine response, and wherein showing is having and do not having two kinds of nucleoprotamine calibration curves among the 0.1M NaCl of 10mM KCl.In fact observed response maximum deviation is no more than 5mV under low nucleoprotamine concentration.
The calibration curve of nucleoprotamine in whole blood
Figure 10 for example understand in the whole blood the nucleoprotamine calibration curve and under the cathode current of-2 μ A the corresponding current potential-time locus of this calibration curve.Discovery potential response scope in whole blood is about 60mV, and this practical measurement for nucleoprotamine in whole blood sample is very gratifying.The standard deviation of current potential is increased to 1.5mV, observes 0.7mV by contrast in the NaCl solution of buffering.The result shows, utilizes the current impulse chronopotentiometric titration, and sensor can be measured the nucleoprotamine concentration that is low to moderate 0.5mg/L.
Embodiment 11
The titration of whole blood sample
This embodiment can be used for measuring heparin in the blood via the end point determination of nucleoprotamine titration, its with the previous class of operation that adopts the potentiometric titration sensor seemingly.Little aliquot (2 * 10 with the heparin stock solution
-5M 1.5g/L) adds in the whole blood sample, so that obtain different typical heparin concentration in 0.25-2 μ M (0.6-4.5kU/L) scope, and carries out titration with the 1g/L nucleoprotamine.The gained titration curve is shown among Figure 11 A.
The each point that calculates is the mean value of 10 continuous electrograms, obtains being not more than the standard deviation of 1.5mV.Estimate repeatability by each titration is repeated 4 times, the deviation that has obtained the take-off potential from a sample to another sample and finished current potential is below 7mV, and total variation of current potential keeps identical in titration process.Because each receiving tube contains the sylvite of 7.2mg EDTA and the blood flow volume collected in each pipe is to change between 2-4mL, most of deviation is attributable to the variation (referring to Fig. 9 B) of potassium concn.
The observed terminal point that is plotted among Figure 11 B is the function of whole blood heparin concentration, and has found the linear relationship (related coefficient 0.995) of expection.The linear regression of gained calibration curve is measured as C
Heparin=V (6.6 ± 0.4) * 10
-3M/L-0.6 μ M.
Embodiment 12
Life-span and sensor stability
The life-span of sensor and stability are important parameters, are to carry out in Physiological Medium if especially measure.3 hours the continuous impulse chronopotentiometric titration measurement (measuring intervals of TIME is 1 minute) in containing the pH buffering 0.1M NaCl of 10mg/L nucleoprotamine does not produce significant potential drifting and maximum potential is changed to 2mV.For whole blood sample, the titration curve that is shown in Figure 11 B is to utilize identical sensor to obtain, and the overall measurement time in blood surpasses 2.5 hours (for each point, having collected 10 potential measurement values).After in being exposed to blood, sensor is positioned among the 0.1M NaCl of buffering, finds that the baseline current potential turns back to initial value (for each sensor ± 5mV).The life-span of sensor (being defined as the time that the baseline potential change is no more than 20mV) was at least 2 weeks, and the T.T. that is exposed in the undiluted whole blood sample is 10 hours.
Embodiment 13
Preparation nucleoprotamine selective membrane electrode and mensuration tryptic activity and inhibitor activity
It is 1: 2 PVC and the lipophilicity salt TDDA-DNNS of o-NPOE and 5wt% that ion selective membrane (thickness is 200 μ m) contains weight ratio.THF is as solvent in employing, casts by solvent streams to prepare this film.Be cut into this film by female film and attach it in the Philips electrode body (S-561) with cork borer (diameter is 6-mm).Interior filling solution is made up of in 10mMTris-HCl buffering agent (pH=7.4) 0.1M NaCl and is contacted with inner Ag/AgCl electrode.With one night of this electrode regulating, the binode Ag/AgCl electrode with 1MLiOAc bridge electrolytic solution is used as outer contrast electrode before experimentizing in the solution identical with interior filling solution.
The Pulstrode measurement is carried out in the three-electrode battery system, and wherein Philips body electrode (as working electrode), outer contrast electrode and counter electrode (platinum line) are dipped in this sample.Utilize pulse continuous current/constant potential technology to control ion selective membrane.At experimental session, the current density that at every turn applies is 0.5 μ A/cm
2Be another zero continuous current pulse (duration is 0.5 second) after the continuous current pulse of (duration is 0.5 second), add constant potential pulse (duration is 15 seconds) then.The mean value of the sampling current potential that can represent sensor response during as the last 50ms of first current impulse.
Nucleoprotamine has the basic amino acid of high-load, and wherein about 50% has arginine residues.Therefore, it is the good zymolyte that is used for the trypsinization reaction.Shown in Figure 12 a and Figure 12 b, when adding high concentration proteases trypsin enzyme, the response of nucleoprotamine significantly reduces, and proteolysis reaction has appearred in this expression.Adopt identical electrode all to test, and between the different measurement of trypsinase concentration, clean this film as background solution with identical buffering agent.The baseline total displacement is about 7mV, and it represents the efficient recovery that has of sensing membrane.
The slope that initial potential descends during by interpolation trypsase can be assessed the reaction rate of trypsinization nucleoprotamine.The slope of Xia Jianging means that when trypsinase concentration increases reaction rate strengthens gradually, therefore, shown in nucleoprotamine digestion and the sample tryptic activity in direct ratio.
Be in the past utilize potentiometric titration nucleoprotamine sensor directly to detect the active of protease inhibitors and successfully measured in the pre-service plasma sample like the trypsin inhibitor Aprotinin.Utilize Pulstrode nucleoprotamine sensor can assess the activity of tryptic soy inhibitor.By under the changeless trypsinase concentration of every milliliter 50 unit, inhibitory reaction speed is estimated in the variation of current potential and nucleoprotamine concentration during initial 96 seconds after the potpourri that adds trypsase and soybean inhibitor.Result with respect to the soybean inhibitor concentration has been shown in Figure 13 a and 13b.Figure 13 a shows the potential change with respect to the soybean inhibitor concentration, and Figure 13 b shows the nucleoprotamine concentration change with respect to the soybean inhibitor concentration.When the soybean inhibitor concentration increases, shown in reaction rate reduce.
The instruction that the technician who belongs to field of the present invention provides in having benefited from narrating in front can be learnt many modification of the present invention described herein and other embodiment.Therefore, should be understood that the invention is not restricted to disclosed specific embodiment and these modification and other embodiment is believed to comprise within the scope of the appended claims.Though used particular term here, they only are used for the meaning described with generality, and purpose without limits.
Claims (42)
1. sensor, it comprises:
Be positioned at the electrode of shell, and
Be arranged in this shell an end and with the outer contacted film of sample solution of shell, the polyion concentration in the wherein said film test sample solution, and wherein said polyion concentration to reduce the interior enzymatic activity of speed and described sample solution in direct ratio.
2. sensor according to claim 1, wherein said electrode are the Ag/AgCl electrodes.
3. sensor according to claim 1, the surface area of wherein said film is about 10mm
2-100mm
2
4. sensor according to claim 3, the surface area of wherein said film is about 20mm
2-50mm
2
5. sensor according to claim 1, the average thickness of wherein said film are about 10 μ m-1000 μ m.
6. sensor according to claim 5, the average thickness of wherein said film are about 20 μ m-300 μ m.
7. sensor according to claim 1, the concentration of wherein said polyion are the concentration of nucleoprotamine.
8. sensor according to claim 1, the activity of wherein said enzyme are tryptic activity.
9. the method for polyion concentration in the test sample solution, this method comprises:
A kind of sample solution is provided; And
This sample solution is contacted with film, and wherein said film detects the polyion concentration in this sample solution, and the enzymatic activity that reduces in speed and the described sample solution of wherein said polyion concentration is in direct ratio.
10. method according to claim 9, the concentration of wherein said polyion are the concentration of nucleoprotamine.
11. method according to claim 9, the activity of wherein said enzyme are tryptic activity.
12. method according to claim 9, wherein said sample solution comprises biotic component.
13. method according to claim 9, wherein said sample solution is a blood.
14. a reversible fuel cell arrangement, it comprises:
The polyion selective membrane electrode that contains film, wherein said film detect the polyion concentration in this sample solution, and the enzymatic activity that reduces in speed and the described sample solution of wherein said polyion concentration is in direct ratio; And
Be used to apply the device that current potential cleans described film.
15. reversible fuel cell arrangement according to claim 14, wherein said polyion concentration are the concentration of nucleoprotamine.
16. reversible fuel cell arrangement according to claim 14, the activity of wherein said enzyme are tryptic activity.
17. reversible fuel cell arrangement according to claim 14, wherein said to be used to apply the device that current potential cleans described film be the external electrode current potential that applies between contrast electrode and polyion selective membrane electrode.
18. a reversible fuel cell arrangement, it comprises:
The polyion selective membrane electrode that contains film, wherein said film detect the polyion concentration in the described sample solution; And
Be used between contrast electrode and polyion selective membrane electrode, applying current potential to clean the device of described film.
19. a reversible fuel cell arrangement, it comprises:
Polyion concentration in the polyion selective membrane electrode that contains film, wherein said film test sample solution, and the enzymatic activity that reduces in speed and the described sample solution of wherein said polyion concentration is in direct ratio; And
Be used between contrast electrode and polyion selective membrane electrode, applying current potential to clean the device of this film.
20. reversible fuel cell arrangement according to claim 19, the concentration of wherein said polyion are the concentration of nucleoprotamine.
21. reversible fuel cell arrangement according to claim 19, the activity of wherein said enzyme are tryptic activity.
22. one kind makes the fuel cell arrangement reversal method, this method comprises:
A kind of sample solution is provided;
This sample solution is contacted with the polyion selective membrane electrode that contains film, and wherein said film detects the polyion concentration in this sample solution, and the enzymatic activity that reduces in speed and the described sample solution of wherein said polyion concentration is in direct ratio, and
Apply current potential to clean this film.
23. method according to claim 22, the concentration of wherein said polyion are the concentration of nucleoprotamine.
24. method according to claim 22, the activity of wherein said enzyme are tryptic activity.
25. method according to claim 22, wherein said sample solution comprises biotic component.
26. method according to claim 22, wherein said sample solution is a blood.
27. method according to claim 22, the wherein said current potential that is used to clean described film is applied between contrast electrode and the polyion selective membrane electrode.
28. a sensor, it comprises:
Be positioned at the electrode of shell, and
Be arranged in this shell an end and with the outer contacted film of sample solution of shell, wherein said film detects enzymatic activity and the corresponding inhibitor activity in the described sample solution.
29. sensor according to claim 28, wherein said electrode are the Ag/AgCl electrodes.
30. sensor according to claim 28, the surface area of wherein said film is about 10mm
2-100mm
2
31. sensor according to claim 30, the surface area of wherein said film is about 20mm
2-50mm
2
32. sensor according to claim 28, the average thickness of wherein said film are about 10 μ m-1000 μ m.
33. sensor according to claim 32, the average thickness of wherein said film are about 20 μ m-300 μ m.
34. sensor according to claim 28, the activity of wherein said enzyme are tryptic activity.
35. sensor according to claim 28, the activity of wherein said corresponding enzyme inhibitor are the activity of α 1-antiprotease inhibitor.
36. sensor according to claim 28, the activity of wherein said corresponding enzyme inhibitor are the activity of alpha2-macroglobulin.
37. sensor according to claim 28, the activity of wherein said corresponding enzyme inhibitor are the activity of α 1-Aprotinin.
38. sensor according to claim 28, the activity of wherein said corresponding enzyme inhibitor are the activity of soybean inhibitor.
39. sensor according to claim 28, wherein current potential reduces to depend on the concentration of corresponding enzyme inhibitor in the described sample solution.
40. sensor according to claim 28 also comprises being used to detect the immunoassays of deciding by the analyte of label mark.
41. according to the described sensor of claim 40, wherein said label is a polyion.
42. according to the described sensor of claim 40, wherein said label is an enzyme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70611705P | 2005-08-05 | 2005-08-05 | |
US60/706,117 | 2005-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101495838A true CN101495838A (en) | 2009-07-29 |
Family
ID=39167262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200680028701XA Pending CN101495838A (en) | 2005-08-05 | 2006-07-27 | Reversible electrochemical sensors for polysions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1910813A2 (en) |
JP (1) | JP2009503545A (en) |
KR (1) | KR20080053460A (en) |
CN (1) | CN101495838A (en) |
CA (1) | CA2617765A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102313767A (en) * | 2010-06-29 | 2012-01-11 | 中国科学院烟台海岸带研究所 | High-sensitivity polyion-selective electrode and testing method thereof |
CN102445483A (en) * | 2011-09-30 | 2012-05-09 | 中国科学院烟台海岸带研究所 | Method for detecting heparins |
CN103808775A (en) * | 2014-03-13 | 2014-05-21 | 中国科学院烟台海岸带研究所 | Method and device for continuously detecting heparin |
CN106799196A (en) * | 2015-11-26 | 2017-06-06 | 上海美迪维康生物科技有限公司 | DNA fabricated in situ semiconductor chip and its control method |
CN109374720A (en) * | 2018-10-10 | 2019-02-22 | 金华职业技术学院 | A kind of electrolyte intermediate ion apparatus for measuring concentration |
CN114058677A (en) * | 2015-12-18 | 2022-02-18 | 雷迪奥米特医学公司 | Mixed ionophore ion-selective electrode for improved detection of urea in blood |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114544728B (en) * | 2020-11-25 | 2023-10-27 | 中国科学院烟台海岸带研究所 | Thin-layer polymer film ion selective electrode based on pulse constant current control and detection method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1287345A2 (en) * | 2000-05-18 | 2003-03-05 | Medtronic, Inc. | Ion-selective solid-state polymeric membrane electrodes |
US6872297B2 (en) * | 2001-05-31 | 2005-03-29 | Instrumentation Laboratory Company | Analytical instruments, biosensors and methods thereof |
WO2005008232A1 (en) * | 2003-07-09 | 2005-01-27 | Auburn University | Reversible electrochemical sensors for polyions |
-
2006
- 2006-07-27 CN CNA200680028701XA patent/CN101495838A/en active Pending
- 2006-07-27 EP EP06800512A patent/EP1910813A2/en not_active Withdrawn
- 2006-07-27 KR KR1020087002855A patent/KR20080053460A/en not_active Application Discontinuation
- 2006-07-27 CA CA002617765A patent/CA2617765A1/en not_active Abandoned
- 2006-07-27 JP JP2008525068A patent/JP2009503545A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102313767A (en) * | 2010-06-29 | 2012-01-11 | 中国科学院烟台海岸带研究所 | High-sensitivity polyion-selective electrode and testing method thereof |
CN102313767B (en) * | 2010-06-29 | 2013-09-18 | 中国科学院烟台海岸带研究所 | High-sensitivity polyion-selective electrode and testing method thereof |
CN102445483A (en) * | 2011-09-30 | 2012-05-09 | 中国科学院烟台海岸带研究所 | Method for detecting heparins |
CN102445483B (en) * | 2011-09-30 | 2014-01-15 | 中国科学院烟台海岸带研究所 | Method for detecting heparins |
CN103808775A (en) * | 2014-03-13 | 2014-05-21 | 中国科学院烟台海岸带研究所 | Method and device for continuously detecting heparin |
CN106799196A (en) * | 2015-11-26 | 2017-06-06 | 上海美迪维康生物科技有限公司 | DNA fabricated in situ semiconductor chip and its control method |
CN114058677A (en) * | 2015-12-18 | 2022-02-18 | 雷迪奥米特医学公司 | Mixed ionophore ion-selective electrode for improved detection of urea in blood |
CN109374720A (en) * | 2018-10-10 | 2019-02-22 | 金华职业技术学院 | A kind of electrolyte intermediate ion apparatus for measuring concentration |
CN109374720B (en) * | 2018-10-10 | 2024-01-26 | 金华职业技术学院 | Ion concentration measuring device in electrolyte |
Also Published As
Publication number | Publication date |
---|---|
KR20080053460A (en) | 2008-06-13 |
JP2009503545A (en) | 2009-01-29 |
EP1910813A2 (en) | 2008-04-16 |
CA2617765A1 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1846132B (en) | Reversible electrochemical sensors for polyions | |
Bakker et al. | Ionophore-based membrane electrodes: new analytical concepts and non-classical response mechanisms | |
van de Velde et al. | Solid contact potassium selective electrodes for biomedical applications–a review | |
Buck et al. | Peer reviewed: tracing the history of selective ion sensors | |
Amemiya et al. | Electrochemical heparin sensing at liquid/liquid interfaces and polymeric membranes | |
CN101495838A (en) | Reversible electrochemical sensors for polysions | |
JPH0633063U (en) | Graphite-based solid polymer membrane ion-selective electrode | |
Armas et al. | Ready-to-use single-strip paper based sensor for multiplex ion detection | |
JP2006514307A (en) | Polymer membranes for use in electrochemical sensors | |
Bartoszewicz et al. | Calibration free solid contact electrodes with two PVC based membranes | |
Ferguson et al. | Advances in electrochemical and optical polyion sensing: A review | |
Bakker et al. | Advances in potentiometry | |
CN105784814A (en) | Sensor based on concentration cell principle | |
AU639005B2 (en) | Electrochemical cell, reference electrode and electrochemical method | |
Cosofret et al. | Electrochemical characterization of aminated PVC‐based ion‐selective membranes | |
US8097135B2 (en) | Reversible electrochemical sensors for polyions | |
Eine et al. | Towards a solid state reference electrode | |
Wang et al. | A moving-part-free protamine-sensitive polymeric membrane electrode for sensitive biomedical analyses | |
CN114019005B (en) | High-precision electrochemical detection method for polymer sensitive film based on ion migration amplification effect | |
Gemene et al. | Flash chronopotentiometric sensing of the polyions protamine and heparin at ion-selective membranes | |
Lewenstam | Clinical analysis of blood gases and electrolytes by ion-selective sensors | |
Wang et al. | Primary-ion-conditioned polymeric membrane electrodes for sensitive detection of polyions | |
Mi et al. | Ion Binding Properties of the Lipophilic H+‐Chromoionophore ETH 5294 in Solvent Polymeric Sensing Membranes as Determined with Segmented Sandwich Membranes | |
Henn et al. | Voltammetric Ion‐Selective Electrodes (VISE) | |
Scheipers et al. | Potentiometric ion-selective silicon sensors for the on-line monitoring of blood electrolytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090729 |